This morning, Matt Bailey, NABR and Foundation for Biomedical Research (FBR) president, expressed concerns in an article by CNN covering the recent decision by the Food & Drug Administration (FDA) to end nicotine studies with primates.
Countering claims by Justin Goodman, Vice President of Advocacy and Public Policy of the animal rights organization the White Coat Waste Project (WCW), that such research is a misuse of federal tax dollars, Bailey said, “Research into the effects of nicotine is indeed a public health issue, especially given the rise in popularity of vaping devices among teenagers.” Adding, "My understanding is that the research project in question aimed to determine whether there is or is not a safe level of nicotine absorption by young people." "That's an important question," said Bailey.
Bailey also addressed concerns regarding additional regulatory burden, saying any efforts to augment animal care must be done without impeding the speed of finding breakthroughs. "Additional oversight efforts need to be balanced by efforts to reduce the significant amount of regulatory burden felt daily by research scientists in the US."
"Animals played a role in the development of each of the top 25 most prescribed drugs in America," Bailey said. Adding that our pets, farm animals and wildlife also benefit from medical treatments developed in part from animal research, he noted, "Farm animals and wildlife are routinely vaccinated against any number of diseases, but those vaccines wouldn't be available without animal research. So if you love animals, you really should support animal research."
"Undoubtedly, some will argue that this recent action by the FDA is a reason to end research with animal models. But given the inextricable role humane and responsible animal research plays in the health of the overall population, and the health of the animals about which we care so deeply, that is a very dangerous proposition," he said.
Please click here to read Bailey’s interview by CNN